Crossmark

Biological activities of optimized biosynthesized selenium nanoparticles using Proteus mirabilis PQ350419 alone or combined with chitosan and ampicillin against common multidrug-resistant bacteria

Crossref DOI link: https://doi.org/10.1186/s12934-025-02783-0

Published Online: 2025-07-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elshikiby, Laila A.

Baka, Zakaria A.M.

El-Zahed, Mohamed M. https://orcid.org/0000-0003-2694-3720
Funding

Funding for this research was provided by:

Damietta University
License Information

Text and Data Mining valid from 2025-07-05

Version of Record valid from 2025-07-05
More Information

Article History

Received: 27 March 2025

Accepted: 24 June 2025

First Online: 5 July 2025

Declarations

:

: The study was carried out in accordance with the guidelines and regulations of the scientific research ethics committee, Faculty of Science, Damietta University, Egypt. Written informed consent for enrolment, screening, and specimen collection was obtained from each patient or their parents or guardians. The data of the specimens were not exposed. The cytotoxicity experiments were conducted in compliance with the IACUC (The Institutional Animal Care and Use Committee) statement for using animals in research and teaching by the local ethical committee of AUHA (Al-Azhar University Housing Animals).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below